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1. Introduction
Thanks to  their  low cost  and their  broad spectrum of  activity  in  preventing or  treating
bacterial infections, sulfonamides (SAs) are one of the oldest groups of veterinary chemo‐
therapeutics, having been used for more than fifty years. To a lesser extent they are also
applied in human medicine.  After  tetracyclines,  they are the most  commonly consumed
veterinary  antibiotics  in  the  European  Union.  As  these  compounds  are  not  completely
metabolized,  a  high  proportion  of  them  are  excreted  unchanged  in  feces  and  urine.
Therefore, both the unmetabolized antibiotics as well as their metabolites are released either
directly to the environment in aquacultures and by grazing animals or indirectly during the
application of manure or slurry [1-3].
Physico-chemical properties and chemical structures of selected SAs are presented in Table
1. They are fairly water-soluble polar compounds, the ionization of which depends on the
matrix pH. All the sulfonamides, apart from sulfaguanidine, are compounds with two basic
and one acidic functional group. The basic functional groups are the amine group of aniline
(all the SAs) and the respective heterocyclic base, specific to each SA. The acidic functional
group in the SAs is the sulfonamide group. With such an SA structure, these compounds may
be described by the pKa1, pKa2 and pKa3 values corresponding to the double protonated, once
protonated and neutral forms of SA (Table 1) [3-7].
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Substance
[CAS]
Abbreviation
Chemical structure Selected physico-chemical
properties
Sulfaguanidine
[57-67-0]
SGD NH2 S
O
O
NH C
NH
NH2
M = 214.2 g mol-1
pKa2 = 2.8
pKa3 = 12.0
logP = -1.22
Sulfapyridine
[144-83-2]
SPY
NH2 S
O
O
HN
N
M = 249.2 g mol-1
pKa2 = 2.37
pKa3 = 7.48
logP = 0.03
Sulfadiazine
[68-35-9]
SDZ
NH2 S
O
O
HN N
N
M = 250.3 g mol-1
pKa2 = 1.98
pKa3 = 6.01
logP = -0.09
Sulfamethoxazole
[723-46-6]
SMX
NH2 S
O
O
HN
ON M = 253.3 g mol-1pKa2 = 1.81
pKa3 = 5.46
logP = 0.89
Sulfathiazole
[72-14-0]
STZ
NH2 S
O
O
HN N
S M = 255.3 g mol-1
pKa2 = 2.06
pKa3= 7.07
logP = -0.04
Sulfamerazine
[127-79-7]
SMR
NH2 S
O
O
HN N
N
M = 264.3 g mol-1
pKa2 = 2.16
pKa3 = 6.80
logP = 0.11
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Substance
[CAS]
Abbreviation
Chemical structure Selected physico-chemical
properties
Sulfisoxazole
[127-69-5]
SSX
NH2 S
O
O
HN
O N M = 267.3 g mol
-1
pKa2 = 2.15
pKa3= 5.00
logP = 1.01
Sulfamethiazole
[144-82-1]
SMTZ
NH2 S
O
O
HN
S
NN
M = 270.3 g mol-1
pKa2 = 2.24
pKa3 = 5.30
logP = 0.47
Sulfadimidine
(sulfamethazine)
[57-68-1]
SDMD (SMZ)
NH2 S
O
O
HN N
N
M = 278.3 g mol-1
pKa2 = 2.46
pKa3 = 7.45
logP = 0.27
Sulfamethoxypyridazine
[80-35-3]
SMP
NH2 S
O
O
HN
NN
OMe
M = 280.3 g mol-1
pKa2 = 2.20
pKa3 = 7.20
logP = 0.32
Sulfachloropyridazine
[80-32-0]
SCP
NH2 S
O
O
HN
NN
Cl
M = 284.7 g mol-1
pKa2 = 1.72
pKa3 = 6.39
logP = 0.71
Sulfadimethoxine
[122-11-2]
SDM NH2 S
O
O
NH
N
N
OMe
OMe
M = 310.3 g mol-1
pKa2 = 2.5
pKa3 = 6.0
logP = 1.63
Table 1. Structures and physico-chemical properties of selected sulfonamides (according to [1,6-13])
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Due to their properties, after disposal in soils, these compounds may enter surface run-off or be
leached into the groundwater. Moreover, they are also quite persistent, non-biodegradable and
hydrolytically stable, which explains why in the last ten years they have been regularly detect‐
ed not only in aquatic but also in terrestrial environments [1-3,7,14]. Although SAs concentra‐
tions in environmental samples are quite low (at the µg L-1 or ng L-1 level), they are continuously
being released [3,15]. Therefore, the kind of exposure organisms may be subjected to will resemble
that of traditional pollutants (e.g. pesticides, detergents), even those of limited persistence.
Consequently, SAs as well as other pharmaceuticals may be considered pseudo-persistent.
SAs are designed to target specific metabolic pathways (they competitively inhibit the conver‐
sion of p-aminobenzoic acid, PABA) by inhibiting the biosynthetic pathway of folate (an essential
molecule required by all living organisms), so they not only affect bacteria (target organisms) but
can also have unknown effects on environmentally relevant non-target organisms, such as
unicellular algae, invertebrates, fish and plants [16-18]. Belonging to different trophic levels, these
taxonomic groups may be exposed to by SAs to various extents [15-16,19-20].
However, knowledge of the potential effects of SAs on the environment is very limited.
Recently, a few review papers have been published that summarize the available ecotoxicity
data of pharmaceuticals, including some sulfonamides [16-17,19-21]. Such data as are available
on the potential effects of pharmaceuticals in the environment appear to indicate a possible
negative impact on different ecosystems and imply a threat to public health. However, if we
look just at the sulfonamides, most current studies have investigated acute effects mainly of
single compounds and mostly with reference to sulfamethoxazole (SMX), one of the most
common SAs, used in both veterinary and human medicine [16-17,20]. Available information
on the ecotoxicity of selected sulfonamides has been review and is presented in Table 2.
Substance Bacteria
Vibrio
fischeri
Green algae /
Cyanobacteria/
Diatom*
Plants** Invertebrates*** Vertebrates****
SGD >50(30 min) 43.56(96h, P. subcapitata) 30.30(7d, L.gibba) 0.87(48h, D. magna)
3.40(96h, S. dimorphus) 0.22(7d, L. minor)
16.59(96h, S. leopoliensis)
3.42(24h, S.vacuolatus)
SPY >50(30 min) 5.28(24h, S.vacuolatus) 0.46(7d, L. minor)
SDZ >25(30 min) 7.80(72h, P. subcapitata) 0.07(7d, L. minor) 221(48h, D. magna)
2.19(72h, P. subcapitata) 13.7(21d, D. magna)
0.135(72h, M. aeruginosa) 212(48h, D. magna)
2.22(24h, S.vacuolatus)
SMX 23.3(30 min) 1.53(72h, P. subcapitata) 0.081(7d, L.gibba) 189.2(48h, D.magna) 123.1(48h, D.magna) >750(48h, O. latipes) a
>84(30 min) 0.15(96h, P. subcapitata) 0.132(7d, L.gibba) 177.3(96h, D.magna) 205.1(48h, D.magna) 562.5(96h, O. latipes) a
78.1(15 min) 0.52(72h, P. subcapitata) 0.0627(14d, D.carota) 25.2(24h, D. magna) 70.4(48h, M.macrocopa) 27.36(24h, O. myskiss)
74.2(5 min) 2.4(96h, C. meneghiniana) 0.0612(21d, D.carota) 15.51(48h, C. dubia) 84.9(24h, M.macrocopa)
>100(30 min) 0.0268(96h, S. leopoliensis) 0.0454(28d, D.carota) 0.21(7d, C. dubia) 9.63(48h, B.calyciflorus)
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Substance Bacteria
Vibrio
fischeri
Green algae /
Cyanobacteria/
Diatom*
Plants** Invertebrates*** Vertebrates****
1.54(24h, S.vacuolatus) 0.21(7d, L. minor) 100(48h, C. dubia) 35.36(24h, T.platyurus) a
STZ >1000(15min) 13.10(24h, S.vacuolatus) 3.552(7d, L.gibba) 149.3/85.4(48h/96h, D. magna) >500(48h, O. latipes) a
>50(30 min) 4.89(7d, L. minor) 616.7(24h, D. magna) >500(96h, O. latipes) a
391/430(48h/24h, M. macrocopa) >100(48h, O. myskiss) a
135.7/78.9(48h/96h, D. magna)
SMR >50(30 min) 11.90(24h, S.vacuolatus) 0.68(7d, L. minor)
SSX >50(30 min) 18.98(24h, S.vacuolatus) 0.62(7d, L. minor)
SMTZ >100(30 min) 24.94(24h, S.vacuolatus) 2.54(7d, L. minor)
SDMD 344.7(15 min) 19.52(24h, S.vacuolatus) 1.277(7d, L. gibba) 174.4/158.8(48h/96h, D. magna) >500(48h, O. latipes) a
>100(30 min) 1.74(7d, L. minor) 215.9/506.3(48h/24h, D. magna) >500(96h, O. latipes) a
111/311(48h/24h, M. macrocopa)
185.3/147.5(48h/96h, D. magna)
SMP >100(30 min) 3.82(24h, S.vacuolatus) 1.51(7d, L. minor)
SCP 26.4(15 min) 32.25(24h, S.vacuolatus) 2.33(7d, L. minor) 375.3/233.5(48h/96h, D. magna) 589.3(48h, O. latipes) a
>50(30 min) 2.48(7d, L. minor) 535.7(96h, O. latipes) a
SDM >500(15 min) 2.30 (72h, P. subcapitata) 0.445(7d, L.gibba) 248.0/204.5(48h/96h, D. magna) >100(48h, O. latipes) a
>500(5 min) 11.2 (72h, C. vulgaris) 0.248(7d, L.gibba) 270/639.8(48h/24h, D. magna) >100 (96h O. latipes) a
>50(30 min) 9.85(24h, S.vacuolatus) 0.02(7d, L. minor) 184/297(48h/24h, M. macrocopa)
SQO b 0.25(96h, P. subcapitata) 13.55(7d, L.gibba) 3.47(48h, D. magna)
0.45(96h, S. dimorphus) 2.33(7d, L. minor)
2.83(96h, S. leopoliensis)
* green algae: Pseudokirchneriella subcapitata (previously Scenedesmus capricornutum), Scenedesmus dimorphus, Chlorella vulgaris; cya‐
nobacteria Synechococcus leopoliensis, Microcystis aeruginosa; diatom Cyclotella meneghiniana;
** duckweed Lemna gibba, Lemna minor, carrot Daucus carota;
*** crustacean: Moina macrocopa, Clathrina dubia, Thamnocephalus platyurus, Daphnia magna; rotifer: Brachionus calyciflorus;
**** fish: Oryzias latipes, rainbow trout Onchorhynchus mykiss;
Table 2. Summary of the ecotoxicological risk (described by EC50 or LC50a in mg L-1) estimated for different
sulfonamides (data obtained from [16,19-20,22-33]); b sulfaquinoxaline
This demonstrates the lack of data relating to the long-term exposure of non-target organisms,
and especially how continuous exposure for several generations may affect a whole popula‐
tion. Moreover, as these compounds occur in natural media not as a single, isolated drug but
usually together with other compounds of the same family or the same type, accumulated
concentrations or synergistic-antagonistic effects can be also observed. The simultaneous
presence of several pharmaceuticals in the environment may result in a higher level of toxicity
towards non-target organisms than that predicted for individual active substances.
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Therefore, the main aim of this chapter was to review the existing knowledge on the chronic
and mixture toxicity of the residues of sulfonamides in the environment, since it has not been
done yet. This will be achieved by: (1) presenting current approaches for Environmental Risk
Assessment (ERA) for pharmaceuticals with respect to the evaluation of chronic and mixture
toxicity of these compounds; (2) introducing the reader to basic concepts of chemical mixture
toxicology; and finally (3) by discussing detailed available information on chronic and mixture
toxicity of the residues of sulfonamides in the environment.
2. Environmental risk assessment of pharmaceuticals vs. chronic and
mixture toxicity of pharmaceuticals
The approaches currently being used to assess the potential environmental effects of human
and veterinary drugs in the U.S. and in the European Union are in some respects dissimilar
[34-39]. The Environmental Risk Assessment (ERA) process usually starts with an initial
exposure assessment (Phase I). But with some exceptions, a fate and effects analysis (Phase II)
is only required when exposure-based threshold values, the so-called action limits, are
exceeded in different environmental compartments. Thus risk assessment, described by Risk
Quotient (RQ), is performed by the calculation the ratio of the predicted (or measured)
environmental concentration (PEC or MEC respectively) and predicted biological non-
effective concentrations (PNEC) on non-target organisms. If RQ is less than one it indicates
that no further testing is recommended. Calculations of environmental concentrations rely e.g.
on information on treatment dosage and intensity along with default values for standard
husbandry practices, and are based on a total residue approach reflecting worst-case assump‐
tions. For example, the recently introduced European guidance on assessing the risks of human
drugs excludes the testing of pharmaceuticals whose PECsurface water is below an action limit of
0.01 µg L-1; in the U.S. this threshold value is 0.1 µg L-1. Moreover, there are two different action
limits for veterinary pharmaceuticals, one each for the terrestrial and the aquatic compart‐
ments. No fate and effect analysis is required for veterinary pharmaceuticals used to treat
animals if the PECsoil is < 100 µg kg-1 dry weight of soil. However, a Phase II assessment is not
required for veterinary medicines used in an aquaculture facility if the estimated concentration
of the compound is < 1 µg L-1 [40-41]. If the PECsurface water of a pharmaceutical is above the action
limit, effects on algae, crustaceans and fish are investigated. However, if PECsoil is higher than
the action limit, then Phase II, divided into two parts: Tier A, in which the possible fate of the
pharmaceutical or its metabolites and its effects on earthworms (mortality) and plants
(germination and growth) as well as the effects of the test compound on the rate of nitrate
mineralization in soil are determined; and Tier B in which only effect studies are recommended
for affected taxonomic levels [34-39].
The main problem associated with this approach is the fact that the no actual sales figures or
measured environmental concentrations are at hand when a risk assessment is conducted.
Therefore, only crude PEC calculations are performed [42]. Moreover, the (eco)toxicity tests
included in Phase II focus on acute toxicity of only single compounds. Chronic and mixture
toxicity is not obligatory. As the risk of an acute toxic effect from pharmaceuticals in the
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environment is unlikely and organisms in the environment are exposed to mixtures of
pharmaceuticals, such limited focus results in important uncertainties. Additionally, same
drugs (like sulfonamides) are used to treat both humans and animals. Although the exposures
may differ, their potential effects on non-target organisms will be the same, and so the effect-
testing approaches should be similar. For these reasons, many scientists have already pointed
out the need for more reliable PEC and PNEC calculations for more realistic ERA of pharma‐
ceutical [40-42].
3. Basic concepts of chemical mixture toxicology
To predict the toxicity of mixtures, ecotoxicologists use concepts originally developed by
pharmacologists in the first half of the 20th century [43-48]. Since more than 20 years, they
have been trying to elucidate the problem of risk assessment for complex mixtures of various
substances. As a result a lot of excellent studies have been performed in this topic [49-51].
One of the main interests of scientists in the field of combination toxicology is to find out
whether the toxicity of a mixture is different from the sum of the toxicities of the single
compounds; in other words, will the toxic effect of a mixture be determined by additivity
of dose or effect or by supra-additivity (synergism - an effect stronger than expected on
the basis of additivity) or by infra-additivity (antagonism - an effect lower than the sum of
the toxicities of the single compounds) The toxic effect of a mixture appears to be highly
dependent on the dose (exposure level),  the mechanism of action, and the target (recep‐
tor) of each of the mixture constituents. Thus, information on these aspects is a prerequi‐
site for predicting the toxic effect of a mixture [46-47, 52].
Generally, three basic concepts for the description of the toxicological action of constituents of
a mixture have been defined by Bliss and are still valid half a century later: (1) simple similar
action (concentration addition, CA), (2) simple dissimilar action (independent action, IA), (3)
interactions (synergism, potentiation, antagonism) [45].
Concentration addition (CA), also known as ‘simple joint action’, is based on the idea of a
similar action of single compounds, whereas interpretations of this term can differ consider‐
ably. From mechanistic point of view, similar action means in a strict sense that single
substance should show the same specific interaction with a molecular target site in the
observed organisms. This is a nonintereactive process, which means that the chemicals in the
mixture do not affect the toxicity of one another. Each of the chemicals in the mixture contrib‐
utes to the toxicity of the mixture in proportion to its dose, expressed as the percentage of the
dose of that chemical alone that would be required to obtain the given effect of the mixture.
All chemicals of concern in a mixture act in the same way, by the same mechanisms, and differ
only in their potencies [46-47, 52].
It has been shown that the concept of concentration addition is also applicable to nonreac‐
tive,  nonionized  organic  chemicals,  which  show  no  specific  mode  of  action  but  whose
toxicity toward aquatic species is governed be hydrophobicity. The mode of action of such
compounds  is  called  narcosis  or  baseline  toxicity  [53-54].  The  potency  of  a  chemical  to
What Do We Know About the Chronic and Mixture Toxicity of the Residues of Sulfonamides in the Environment?
http://dx.doi.org/10.5772/53732
65
induce  narcosis  is  entirely  dependent  on  its  hydrophobicity,  generally  expressed  by  its
octanol-water  partition  coefficient  logKow.  As  a  result,  in  the  absence  of  any  specific
mechanism of toxicity, a chemical will, within certain boundaries, always be as toxic as its
logKow indicates. Mathematically, the concept of concentration addition for a mixture of n
substances is described by [48]:
∑
i=1
n Ci
ECx i =1 (1)
where ci represents the individual concentrations of the single substances present in a mixture
with a total effect of x%, and ECxi are those concentrations of the single substances that would
alone cause the same effect x as observed for the mixture. According to Eq. (1), the effect of the
mixture remains constant when one component is replaced by an equal fraction of an equally
effective concentration of another. As an important point, concentration addition means that
substances applied at less than their individual “no observable effect concentrations” (NOECs)
can nevertheless contribute to the total mixture effect [46-47].
The alternative concept of independent action (IA), also known as ‘independent joint action’
was already formulated by Bliss [45]. IA is when toxicants act independently and have different
modes of toxic action [43, 46-47]. In this case the agents of a mixture do not affect each other’s
toxic effect. As a result of such a dissimiliar action, the relative effect of one of the toxicants in
a mixture should remain unchanged in the presence of another one. For binary mixture the
combination effect can be calculated by the equitation [46]:
E (cmix)=1 - (1 - E (c1))(1 - E(c2)) (2)
In which E(c1), E(c2) are the effect of single substances and E(cmix) is the total effect of the mixture.
Following this equitation, a substance applied in a concentration below its individual NOEC
will not contribute to the total effect of the mixture, i.e. there will be no mixture toxicity if the
concentrations of all used single substances are below their NOEC [45-47, 52].
Additionally, compounds may interact with one another, modifying the magnitude and
sometimes the nature of the toxic effect. This modification may make the composite effect
stronger or weaker. An interaction might occur in the toxicokinetic phase (processes of uptake,
distribution, metabolism, and excretion) or in the toxicodynamic phase (effects of chemicals
on the receptor, cellular target, or organ).These include terms such as synergism and poten‐
tiation (i.e., resulting in a more than additive effect), or antagonism (i.e., resulting in a less than
additive effect) [52]. It must be highlighted that at given concentrations of the single com‐
pounds in a mixture the combination effect will in general be higher if the substances follow
the concept of concentration addition. Thus, misleadingly the different concepts were some‐
times brought in correlation to the term synergism and antagonism. But synergism or antag‐
onisms between the used substances and their effects can occur independently of a similar or
dissimilar mode of action [46].
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For these reasons, prediction of the effect of a mixture based on the knowledge of each of
the  constituents  requires  detailed information on the  composition of  the  mixture,  expo‐
sure level, mechanism of action, and receptor of the individual compounds. However, often
such information is not or is only partially available and additional studies are needed. In
addition to considering which of these concepts should be used to evaluate combined toxic
effects, the design of the study is important in quantifying the combined effects. Most of
such  studies  are  based  on  a  comparison  of  observed  values  with  those  predicted  by  a
reference  mode  (IA  or  CA).  An  important  aspect  of  toxicity  studies  of  mixtures  is  the
impracticability of ‘complete’ testing. If all combinations are to be studied at different dose
levels, an increasing number of chemicals in a mixture results in an exponential increase
in  number  of  test  groups:  to  test  all  possible  combinations  (in  a  complete  experimental
design) at only one dose level of each chemical in a mixture consisting of 4 or 6 chemi‐
cals, 16 (24–1) or 64 (26–1) test groups, respectively, would be required. Such in vivo studies
are  time consuming and impossible  from a  practical  and economical  point  of  view.  To
reduce  the  number  of  test  groups  without  losing  too  much  information  about  possible
interactions  between  chemicals,  several  test  scenario’s  (statistical  designs)  have  been
proposed [52]. The study design largely depends on the number of compounds of a mixture
and  on  the  question  whether  it  is  desirable  to  assess  possible  existing  interactions  be‐
tween chemicals in a mixture [52]:
• One approach is to test the toxicity of the mixture without assessing the type of interactions.
This is the simplest way to study effects of mixtures by comparing the effect of a mixture
with the effects of all its constituents at comparable concentrations and duration of exposure
at one dose level without testing all possible combinations of two or more chemicals. This
approach requires a minimum number of experimental groups (n + 1, the number of
compounds in a mixture plus the mixture itself). If there are no dose-effect curves of each
of the single compounds it is impossible to describe the effect of the mixture in terms of
synergism, potentiation, antagonism, etc. This strategy would be of interest for a first
screening of adverse effects of a mixture.
• The second approach is based on assessment of interactive effects between two or three
compounds which can be identified by physiologically based toxicokinetic modeling,
isobolographic or dose-effect surface analysis, or comparison of dose-effect curves. How‐
ever, interactive effects of compounds in mixtures with more than three compounds can be
best ascertained with the help of statistical designs such as (fractionated) factorial designs,
ray designs or dose-effect surface analysis. Here we would like to described shortly only
the isobole methods as so far they are mainly used in the studies concerning the determi‐
nation of pharmaceutical mixture toxicity [25-26,46-47].
An  isobole,  originally  developed  by  Loewe  and  Muischnek  [44],  is  a  contour  line  that
represents equi-effective quantities of two agents or their mixtures [52]. The theoretical line
of additivity is the straight line connecting the individual doses of each of the single agents
that produce the fixed effect alone. The method requires a number of mixtures to be tested
and is used for a graphical representation to find out if mixtures of two compounds behave
in a dose-additive manner and subsequently can be regarded as chemicals with a similar
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mode of action. When all equi-effect concentrations are connected by a downward concave
line, the effect of the combinations is antagonistic, and a concave upward curve indicates
synergism. The use of the isobole procedure to evaluate the effects of binary mixtures is
widely  used,  but  is  very  laborious  and  requires  large  data  sets  in  order  to  produce
sufficiently reliable results [52].
4. State of the knowledge concerning mixture and chronic toxicity of the
residues of sulfonamides in the environment
4.1. What do we know about the long-term effects of the presence of the residues of
sulfonamides in the environment?
Chronic toxicity tests are studies in which organisms are exposed to different concentrations
of a chemical and observed over a long period, or a substantial part of their lifespan. In contrast
to acute toxicity tests, which often use mortality as the only measured effect, chronic tests
usually include additional measures of effect such as growth rates, reproduction or changes
in organism behavior [55-56]. Therefore, the standard acute toxicity tests do not seem appro‐
priate for risk assessment of pharmaceuticals, because of the nature of these compounds. The
use of chronic tests over the life-cycle of organisms for different trophic levels could be more
appropriate [57]. However, there is still an ongoing debate between ecotoxicologists over the
determination which tests should be considered to be chronic or acute (based on their dura‐
tion). This applies not only to aquatic animal testing with invertebrates and fish, but also to
standard 96-h algal and 7-d higher plant test methods.
Molander et al. [19] reviewed the data published in the Wikipharma database – a freely available,
interactive and comprehensive database on the environmental effects of pharmaceuticals that
provides an overview of effects caused by these compounds on non-target organisms identi‐
fied in acute, sub-chronic and chronic ecotoxicity tests. Looking at the data set as a whole, they
concluded that crustaceans like Daphnia magna and Ceriodaphnia dubia were the species most
commonly used (29% of all tests performed); this is hardly surprising since they are abundant
and widespread, easy to keep in the laboratory, and sensitive towards a broad range of
environmental contaminants. Less commonly, such tests were performed on marine bacteria
Vibrio fischeri (12%), algae Pseudokirchneriella subcapitata (9.5%) and fish Poeciliopsis lucida (9%)
and Oncorhynchus mykiss (8%) [19]. They have also estimated that acute tests based on
microorganisms (exposure time ≤ 30 min), algae (exposure time ≤ 72 h), invertebrates (exposure
time ≤ 48 h) and vertebrates (exposure time ≤ 96 h) constitute 55% of all the data compiled [19].
This information was corroborated by Santos et al. [20], who estimated that acute effects in
organisms belonging to different trophic levels predominate over chronic ones in more than
60% of all the tests performed. This also concerns the available information on the ecotoxicity
of sulfonamides (see Table 2).
Looking at the available acute toxicity data, it can be concluded that SAs are practically non-
toxic to most microorganisms tested including selected strains of bacteria, such as Vibrio
fischeri and Pseudomonas aeruginosa. However, data as are available from acute tests on the
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potential effects of SAs in the environment appear to indicate a possible negative impact on
different ecosystems and imply a threat to public health. The most sensitive assays for the
presence of SAs are bioindicators containing chlorophyll (algea and duckweed) [3, 22-23]. A
highly toxic effect of SMX on duckweed (Lemna gibba) was observed. This was also supported
by the results of one of our studies, where we evaluated the ecotoxicity potential of twelve
sulfonamides (sulfaguanidine, sulfadiazine, sulfathiazole, sulfamerazine, sulfamethiazole,
sulfachloropyridazine, sulfamethoxypyridazine, sulfamethoxazole, sulfisoxazole, sulfadime‐
thoxine, sulfapyridine, sulfadimidine) to enzymes (acetylcholinesterase and glutathione
reductase), luminescent marine bacteria (Vibrio fischeri), soil bacteria (Arthrobacter globiformis),
limnic unicellular green algae (Scenedesmus vacuolatus) and duckweed (Lemna minor). We found
that SAs were not only toxic towards green algae (EC50 = 1.54 – 32.25 mg/L) but were even more
strongly so towards duckweed (EC50 = 0.02 – 4.89 mg/L) than atrazine, a herbicide (EC50 = 2.59
mg/L) [33]. This indicates that even low concentrations of SAs may significantly affect the
growth and development of plants.
However, data relating to the long-term exposure of non-target organisms, and especially how
continuous exposure for several generations may affect a whole population is very limited.
Most chronic toxicity data for sulfonamides, is available for invertebrates, probably because
these are the briefest and therefore least expensive chronic toxicity tests to run. Available
chronic toxicity data for sulfonamides is summarized in Table 3 and discussed below.
The major concern over the effects of all antimicrobials (including sulfonamides) on microbial
assemblages is the development of antimicrobial resistance and the effect of this on public
health. Recently, Baran et al. [3] has reviewed the papers concerning the influence of presence
of SAs in the environment to antimicrobial resistance. They concluded that SAs in the envi‐
ronment increase the antimicrobial resistance of microorganisms and the number of bacterial
strains resistant to SAs increases systematically in recent years. Resistant bacterial species
commonly carried single genes, but in recent years, an increased number of pathogens that
possess three SAs-resistant genes have been observed. Moreover, they have also highlighted
that these drugs have shown the highest drug resistance, almost twice as high as tetracyclines
and many times higher than other antibiotics. Most often, bacterial resistance to SAs has been
described in Escherichia coli, Salmonella enterica and Shigella spp. from the manure of farm
animals, from meat and from wastewater [3]. The implications of antimicrobial resistance for
aquatic ecosystem structure and function remain unknown, but the human health implications
of widespread resistance are of clear concern [55].
Additionaly, Heuer and Smalla [58] investigated the effects of pig manure and sulfadiazine
on bacterial communities in soil microcosms using two soil types. In both soils, manure and
sulfadiazine positively affected the quotients of total and sulfadiazine-resistant culturable
bacteria after two months. The results suggest that manure from treated pigs enhances spread
of antibiotic resistances in soil bacterial communities. Monteiro and Boxall [59] have recently
examined the indirect effects of sulfamethoxazole on the degradation of a range of human
medicines in soils. It was observed that the addition of SMX significantly reduce the rate of
degradation of human non-steroidal anti-inflammatory drugs, naproxen. This observation
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may have serious implications for the risks of other compounds that are applied to the soil
environment such as pesticides.
Substance name Type of organism Acute toxicity Chronic toxicity Ref.
SDZ Daphnia magna
EC50, 48h = 221 mg L-1 EC50, 21d = 13.7 mg L-1 [60]
(166 – 568 mg L-1) (12.2 – 15.3 mg L-1)
SMX
Brachionus calyciflorus
EC50, 24h = 26.27 mg L-1 EC50, 48h = 9.63 mg L-1
[29]
(16.32 – 42.28 mg L-1) (7.00 – 13.25 mg L-1)
Clathrina dubia
EC50, 48h = 15.51 mg L-1 EC50, 7d = 0.21 mg L-1
(12.97 – 18.55 mg L-1 (0.14 – 0.39 mg L-1)
-logEC50, 15 min -logEC50, 24h
SDMD
SPY
SMX
SDZ
SSX
SMMa
SCP
Photobacterium phosphoreum
3.12 (± 0.04) M
2.92 (± 0.05) M
3.32 (± 0.04) M
3.32 (± 0.02) M
3.81 (± 0.02) M
3.67 (± 0.03) M
4.30 (± 0.04) M
4.08 (± 0.06) M
3.84 (± 0.04) M
4.45 (± 0.05) M
4.50 (± 0.06) M
4.43 (± 0.03) M
5.05 (± 0.05) M
4.78 (± 0.04) M
[61]
SQO
Daphnia magna
EC50, 48h = 131 mg L-1 EC50, 21d = 3.466 mg L-1
[25-26]
(119 – 143 mg L-1) (2.642 – 4.469 mg L-1)
SGD
EC50, 48h = 3.86 mg L-1 EC50, 21d = 0.869 mg L-1
(3.19 – 5.08 mg L-1) (0.630 – 1.097 mg L-1)
SDMD
EC50, 48h = 202 mg L-1 EC50, 21d = 4.25 mg L-1
(179 – 223 mg L-1) (3.84 – 4.62 mg L-1)
SDMD Daphnia magna
EC50, 48h = 215.9 mg L-1 EC50, 21d
[16]
(169.6 – 274.9 mg L-1) no effect up to 30 mg L-1
STZ
EC50, 48h = 616.9 mg L-1 LOEC = 35 mg L-1
(291.7 – 1303.6 mg L-1)
SDMD Moina macrocopa
EC50, 48h = 110.7 mg L-1 EC50, 8d
(89.5 – 136.9 mg L-1) no effect up to 35 mg L-1
STZ
EC50, 48h = 391.1 mg L-1 no effect up to 30 mg L-1
(341.9 – 440.3 mg L-1)
aSulfamonometoxine
Table 3. An overview of the available information on the chronic toxicity of sulfonamides to different organisms
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Only  few  studies  have  also  explored  effects  of  SAs  on  aquatic  microbes.  It  must  be
highlighted that it was already proved that the effects of antibiotics like SAs on bacteria
should not be determined using acute tests.  These compounds possess specific  mode of
action and impacts frequently became evident upon extending the incubation period. Most
of the toxicity data available for Vibrio fischeri using short exposure times (between 5 and
30 min) rather than a 24 h exposure show that SAs have a low toxic potential in this respect,
because these compounds interfere only slightly with biosynthetic pathways. Toxicity tests
with bacteria have shown that chronic exposure to antibiotics is crucial rather than acute
[14,50, 62-63]. This is also supported by the results of [30,61,64]. The toxicity of sulfadimi‐
dine  (sulfamethazine)  in  standard  15  min  acute  test  with  this  luminescent  bacteria  ob‐
tained EC50 was 344.7 mg L-1 [30] but in 18 h test its toxicity was in the range of 3.68 – 4.57
mg L-1 depending on the type of strain of these marine bacteria [64]. Also Zou et al. [61]
determine the chronic (24 h exposure) and acute (15 min exposure) toxicity to Photobacteri‐
um phosphoreum for seven SAs. These experiments revealed that sulfachloropyridazine (SCP)
was more toxic than other SAs, whereas sulfapyridine (SPY) was relatively less toxic than
other SAs (see Table 3).  The order of acute toxicity was as follows: SCP > SSX > SMX >
SMM > SDZ > SDMD > SPY. However, the order of chronic toxicity was different: SMM >
SCP > SDZ > SMX > SSX > SDMD > SPY. Clearly, different order of toxicity between the
acute and chronic exposure indicated a different toxicity mechanism (see Fig. 1). It has been
reported that the acute toxic effects of pollutants to P. phosphoreum are caused by interfer‐
ing LUC-catalyzed bioluminescent reaction and therefore LUC was found to be the receptor
protein for the antibiotics. In contrast, the receptor for the antibiotics in the chronic toxicity
test was dihydropterinic acid synthetase (DHPS).
Studies conducted on the toxicity mechanism of single SAa indicated that the pKa played a
vital role in the toxic effect of SAs or their antibacterial activity [32]. Because LUC (Lucyferase)
is an endoenzyme, and SAs have to be transported into the cell before bind with LUC, it was
clear that the antibiotic toxicity included both LUC-binding and a toxic transportation effect
Figure 1. (A) Scheme of SA ionization in equilibrium, (B) Mechanism for synergistic effect between SA and TMP in bac‐
terium (adopted from Reference [61])
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(which can be described using pKa). pKa is a decisive factor in transporting SAs into the cell.
Three species (neutral, cationic and anionic) of SAs depend on the pKa and surrounding pH
values. The neutral species have higher cell membrane permeability than anionic species.
Therefore, pKa was the key parameter of sulfonamides toxic effects. Some similarity in acute
and chronic toxicity mechanisms was observed. However, in conclusion the distinct receptor
proteins of SAs in acute toxicity and chronic toxicity led to the different toxicity mechanisms
of single antibiotics [61]. A comparison of the results of short and long term bioassays with
Vibrio fischeri demonstrates the risk of underestimating the severe effects of substances with
delayed toxicity in acute tests.
Similar conclusions can be obtained if only acute toxicity of SAs to invertebrates is taken
into consideration.  Detailed information is  presented in  Table  3.  No acute  effects  on D.
magna were observed in the investigation of Wollenberger et al. [60]. However, reproduc‐
tive effects (EC50) were observed for sulfadiazine in the range of 5 to 50 mg L-1. This drug
caused mortality in the parent generation during the long-term (3 weeks) exposure. Such
results  suggest  that  crustacean reproduction test  should be included in the test  strategy
[60]. Similar correlation was also found by Isidori et al. [29] who investigated the acute and
chronic toxicity of SMX to B. calciflorus (24 h and 48 h exposure) and C. dubia (48 h and 7
d exposure time). As expected chronic tests showed higher toxicity that acute tests. Also
Park and Choi [16] evaluated the acute and chronic aquatic toxicities of four SAa using
standard tests with D. magna and M. macrocopa. The results from the chronic toxicity tests
in  this  study  showed  that  sensitivity  of  M.  macrocopa  was  similar  to  that  of  D.  magna.
However, the exposure duration for M. macrocopa was only 8 days whereas for D. magna
was  21  days.  Moina  shares  many  characterisitcs  with  D.  magna  (e.g.  large  population
densities, high population growth rates, short generation time, and easiness of culture) and
is often preferred for hazard evaluation because of its relatively short life span and wide
geographical  distribution.  However,  Park  and  Choi  found  no  significant  effects  on
reproduction of D. magna at concentrations of SMZ up to 30 mg L-1. In contrast De Liguoro
et al. [25-26] observed strong inhibitory effect of SMZ on reproduction of D. magna (nearly
100% inhibition with SMZ at a concentration of 12.5 mg L-1). This could be explained by
that fact that in the Park and Choi study, daphnids were fed daily not only with algae, but
also with the EPA recommended YCT that contains yeast, a known good natural source of
folate [16]. Eguchi et al. [28] have shown that SAs interfere with folate synthesis in green
algae. Therefore, this supplement of folic acid may well have protected the reproduction
of the test organisms by compensating for the deficiencies caused by SMZ. Generally, when
testing antibacterials on D. magna,  effects on the reproductive output occur at concentra‐
tions which are at least one order of magnitude below the acute toxic levels [60].
Unfortunately, there is no information about long-term effects of the residues of these
compounds to higher plants and other aquatic as well as terrestrial organisms. Therefore, it
seems to be necessary for researchers to study the chronic toxicity of antibiotic [46-47, 55]
because of their widespread use and continuous emissions into the environment [14].
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4.2. What do we know about mixture toxicity of the residues of sulfonamides in the
environment?
As SAs occur in natural environment not as a single, isolated drug but usually together with
other compounds of the same family or the same type, accumulated concentrations or
synergistic-antagonistic effects need to be considered. Sulfonamides are widely used in
combination therapy together with their potentiator (mostly trimethoprim, TMP) in human
and veterinary medicine [1-3]; thus, the occurrence of TMP together with other antibiotics has
been commonly detected [3].
Santos et al. [20] pointed out that, ecotoxicological data show that the effects of mixtures may
differ from those of single compounds. For example, Cleuvers [46] showed that a mixture of
diclofenac and ibuprofen exhibited a greater than predicted toxicity to D. magna, and that the
addition of two more drugs increased the toxicity towards the test species even further.
Available mixture toxicity data for sulfonamides is summarized in Table 4 and discussed
below.
Substance name/
Mixture composition
Test scenario
(statistical
design)
Test description
(organism, test
duration)
Toxicity of single
compounds
(EC50single)
Mixture toxicity
(EC50mixture)
Conclusions Ref.
SDM
Evaluation of the
toxicity of the
mixture of
selected
compounds
based on
concentration
addition concept.
Selenastrum
capricornutum,
2.30 mg L-1
Synergistic
growth inhibition
between SAs and
TMP or PMT and
for
SMX:AcSMX:TMP
mixture.
[28]
SMX 1.50 mg L-1
SDZ 2.19 mg L-1
Trimethoprim
(TMP) 80.8 mg L
-1
Pyrimethanine (PMT) 5.06 mg L-1
AcSMX >100mg L-1
AcSDM >100mg L-1
AcSDZ >100mg L-1
SMZ + TMP according to
OECD 201
0.275 mg L-1
SDA + TMP 0.465 mg L-1
SDM + PMT 2.36 mg L-1
SMX:AcSMX:TMP
(20:105:3) 0.784 mg L
-1
SDM:AcSDM:TMP
(176:8:1) 2.17 mg L
-1
SDZ:AcSDZ:TMP
(42:24:1) 2.08 mg L
-1
SDZ
Assessment of
interactive
effects between
two compounds
identified by
Daphnia magna,
48 h
212 mg L-1 Antagonistic
interaction for
mixtures:
SMZ + SDZ
SMZ + SGD
SMZ + SMR
[26]
SGD 3.86 mg L-1
SMR 277 mg L-1
SDM 202 mg L-1
SDMD (SMZ) 270 mg L-1
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SQO
isobologram
method.
SMT + SDM
Complex
interaction
(synergism
additivity and
antagonism) for
mixture of SMT +
SQO
131 mg L-1
TMP 149 mg L-1
binary mixtures of SMZ
+6 compounds
Simple additivity
for SMZ + TMP
SGD Assessment of
interactive
effects between
two compounds
identified by
isobologram
method.
Daphnia magna,
21 d
0.896 mg L-1
Additive
(antagonistic)
interaction
between SQO
and SGD.
[25]
SQO 3.466 mg L-1
SGD Pseudokirchneriella
subcapitata,
96 h
43.559 mg L-1
SQO 0.246 mg L-1
Toxicity of single
compound
(-logEC50, 15 min)
Toxicity of binary
mixture SAs and
TMP(-logEC50, mixture)
[61]
Antagonistic
interaction
between SAs and
TMP in acute
toxicity test.
SDMD
Photobacterium
phosphoreum,
15 min and 24 h
3.12 (± 0.04) M 2.78 (± 0.02) M
SPY Evaluation of the
toxicity of the
mixture of
selected
compounds
based on
concentration
addition concept
2.92 (± 0.05) M 2.89 (± 0.02) M
SMX 3.32 (± 0.04) M 2.79 (± 0.01) M
SDZ 3.32 (± 0.02) M 2.76 (± 0.03) M
SSX 3.81 (± 0.02) M 2.79 (± 0.07) M
SMM 3.67 (± 0.03) M 2.73 (± 0.02) M
SCP 4.30 (± 0.04) M 3.00 (± 0.03) M
TMP 3.22 (± 0.07) M
Toxicity of single
compound
(-logEC50, 24h)
Toxicity of binary
mixture SAs and TMP
(-logEC50, mixture)
SDMD 4.08 (± 0.06) M 5.08 (± 0.05) M
Synergistic
interaction
between SAs and
TMP in chronic
toxicity test.
SPY 3.84 (± 0.04) M 4.85 (± 0.07) M
SMX 4.45 (± 0.05) M 5.50 (± 0.07) M
SDZ 4.50 (± 0.06) M 5.42 (± 0.03) M
SSX 4.43 (± 0.03) M 5.45 (± 0.03) M
SMM 5.05 (± 0.05) M 6.01 (± 0.05) M
SCP 4.78 (± 0.04) M 5.73 (± 0.05) M
TMP 5.37 (± 0.02) M
Table 4. An overview of the available information on the mixture toxicity of sulfonamides to different organisms
The toxicity of mixture of sulfonamides to non-target organisms was firstly reported by Brain
et al. [22] and Eguchi et al. [28]. Brain et al. investigated the toxicity of the mixture of eight
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most commonly used pharmaceuticals belonging to different groups (atorvastatin, acetami‐
nophen, caffeine, sulfamethoxazole, carbamazepine, levofloxacin, sertraline and trimetho‐
prim) to the aquatic macrophytes Lemna gibba and Myriophyllum sibircum. Given the diversity
in mode of action of these compounds, the toxicity of the mixture in the microcosms was likely
via response addition. Generally, both species displayed similar sensitivity to the pharma‐
ceutical mixture [22].
On the other hand, Eguchi et al. [28] found that a mixture of trimethoprim or pyrimethamine
(pyrimethamine is often used as a substitute for trimethoprim), sulfamethoxazole and
sulfadiazine significantly increased growth inhibition (synergistic effect of the mixture was
observed) in the algae S. capricornutum. To investigate the synergistic influence of combined
drugs on the growth of green algae, SAs and TMP or PMT (TMPs) were simultaneously added
to S. capricornutum culture. In this experiment, the concentration of TMPs was fixed at the no
observed effect concentration (NOEC) and the concentration of the SAs were altered. These
combined drugs are frequently used in the veterinary field in many countries. Combination
of SMZ and SDA with TMP rendered the growth inhibitory activity significantly increased in
comparison with their individual activities (see Table 4 and Fig. 2(A)). On the contrary,
combination of SDM with PYR did not show such an effect. Moreover, as SAs are thought to
be partly metabolized to AcSAs in the bodies of animals, Eguchi et al. [28] have also tested the
toxicity of the mixture of SAs their metabolites and TMP. Therefore the test of combined drugs
was done by using the combinations corresponding AcSAs at a ratio according to the concen‐
trations detected in the urine of pigs fed with SAs. The ratio was SMZ:AcSMZ:TMP = 20:105:3,
SDM:AcSDM:PMT = 167:8:1 and SDA:AcSDA:TMP = 42:24:1. A similar synergistic effect to
that described above was observed with combinations of SMZ, TMP, and AcSMZ (see Table
4). However, combination of SDM or SDA with their acetylate and PMT or TMP did not show
a synergistic effect on growth in excretion ratio. A reason must be that the concentration of
TMP used was not enough to express synergistic influence in combination with SDM or SDA.
These results indicate that several combined drugs that show a synergistic effect in vitro may
have an actual synergistic effect on algae in ecosystem although excretion ratio can vary in
animal condition or other factors. The synergistic effect observed by the combination of SAs
and TMPs in this study indicates that the simultaneous release of several antimicrobial agents
may result in greater toxicity to microorganisms in the environment than the release of the
same agents individually. Furthermore, the rate of growth inhibition by SAs by addition of
folic acid was investigated in this study. It was observed that the growth inhibitory activity of
the combination of SDA and TMP was significantly reduced by the addition of 20 ng/l of folic
acid to the medium. Significantly, folic acid exhibited a similar effect when SDA was tested
alone, but not when TMP was tested alone (see Fig. 2(B)) [28].
Both SAs and TMPs inhibit the folate synthesis pathway in bacteria, but their inhibition sites
are different. SAs inhibit dihydropterinic acid synthetase (DHPS), thereby inhibiting the
synthesis of folic acid. On the other hand, TMPs inhibits dihydrofolic acid reductase (DHFR),
which converts folic acid to 7,8-dihydrofolic acid (7,8- DHF) and 5,6,7,8-tetrahydrofolic acid
(5,6,7,8-THF), both active forms of folic acid suitable for utilization. Therefore, the synergistic
effect of the combination of SAs and TMPs is likely to be due to the cumulative effect of their
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actions on two different sites in the folate biosynthesis pathway. Since SAs block the synthesis
of folate, the growth inhibitory effect of this compound can be reversed by the addition of
folate. In contrast, TMP blocks enzymes downstream of folate in the synthesis pathway, thus
addition of folate will not reverse the growth-inhibiting effect of this compound. Since algea
 
(A) 
(B) 
Figure 2. (A) The dose-response curve of SAs (SMT – sufamethzine, SDA – sulfadiazine, SDM – sulfadimethoxine) com‐
bined with TMP (trimethoprim) or PMT (pyrimethamine); (B) Recovery of growth inhibition be addition of folic acid
(*observed siginifcant difference to negative control – without folic acid, 1) concentration of SDA (sulfadiazine) in com‐
bination, TMP was used at the NOEC, 2) used at the EC50 concentration) (adopted from References [28])
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also have a similar folate synthesis pathway, the growth inhibitory effect of SAs on these
organisms is likely to be the result of the same inhibitory mechanism. Therefore, algal cells
could survive in the presence of SAs, but not TMP, when folic acid was added to the medium.
De Liguoro et al. [25-26] evaluated the acute mixture toxicity of combining sulfamethazine
with TMP towards D. magna and effects of different mixtures of sulfaquinoloxine (SQO) and
sulfaguanidine (SGD) on D. magna and P. subcapitata (see Table 4). The additive toxicity of these
compounds was evaluated using the isobologram method. In Fig. 3A, the isoboles showing
the different type of combination effects are presented. Taking into account confidence
intervals SMZ showed infra-additivity when paired with SDZ, SGD, SMA or SDM. When SMZ
was paired with SQO the interaction was more complex, as each type of combination effects
(supra-additivity, additivity and infra-additivity) was observed at the three different combi‐
nation ratios. Simple additivity was recorded when SMZ was combined with the sulfonamide-
potentiator TMP (Fig. 3A). Tests with paired SQO and SGD were based on the individual
EC50 (for D. magna see [25]). In each paired test, the concentration–response relationship was
analyzed for three selected combination ratios equidistantly distributed on the additivity line.
In Fig. 3B, the isoboles based on the effects of different mixtures of SQO and SGD on D.
magna and P. subcapitata are depicted. Only in one test, where relatively low concentrations of
SQO were combined with relatively high concentrations of SGD on P. subcapitata, the two
paired compounds showed simple additivity. In all the other tests a less than additive
(antagonistic) interaction was detected. In this study, binary tests confirmed the tendency of
SAs mixtures to act less than additively. So, in general terms, it seems sufficiently precaution‐
ary to consider their environmental toxicity as additive. However, when combining SQO and
SGD on P. subcapitata, the obtained asymmetric isobologram shows that the interaction is
mixture-ratio dependent, a phenomenon already observed when mixtures of SQO and
sulfamethazine were tested on D. magna [26].
Zou et al. [61] have recently highlighted that these results cannot represent the mixture toxicity
between the SAs and TMP in an actual environment because non-target organisms (microlage
and D. magna) were used in these studies. Bacterium is typically the target-organism of an
antibiotic, and thus in their opinion, a bioassay with Photobacterium phosphoreum is a more
reliable tool to determine the toxicity of various antibiotics. Moreover, most studies focus on
the acute mixture toxicity. Therefore, in their study they have: determined not only the acute
(15 min exposure) but also chronic (24 h exposure) toxicity to P. phosphoreum for single SA and
their potentiator, and for their mixtures (SA with TMP); evaluated the differences between
chronic and acute mixture toxicity; and revealed the difference between their toxicity mecha‐
nisms by using QSAR models. A comparison of chronic vs. acute mixture toxicity revealed the
presence of an interesting phenomenon, that is, that the joint effects vary with the duration of
exposure; the acute mixture toxicity was antagonistic, whereas the chronic mixture toxicity
was synergistic. Based on the approach of QSARs and molecular docking, this phenomenon
was proved to be caused by the presence of two points of dissimilarity between the acute and
chronic mixture toxicity mechanism: (1) the receptor protein of SAs in acute toxicity was LUC,
while in chronic toxicity it was DHPS, and (2) there is a difference between actual concentration
of binding-LUC in acute toxicity and individual binding-DHPS in chronic toxicity (see Fig.
1). The existence of these differences poses a challenge for the assessment of routine combi‐
nations in medicine, risk assessment, and mixture pollutant control, in which, previously, only
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a synergistic effect has been observed between SA and their potentiator. The toxicity effect of
mixtures is associated with the transportation of toxic effects of individual chemicals into cells,
the interaction toxic effects of individual chemical-binding-receptor proteins. According to
Figure 3. (A)D. magna immobilization test: 48 h EC50 isobolograms of SMZ paired with other SAs and TMP at three
selected combination ratios; (B) isobolograms of paired SQO and SGD in D. magna immobilization test (adopted from
References [25-26])
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acute toxicity mechanism of single antibiotics it can be concluded that the transportation toxic
effect is highly related to pKa values and the interaction toxic effect can be described by LUC-
SAs binding or LUC-TMP binding. The synergistic effect between SAs with TMP has also been
observed in the field of medicine and proved to be caused by the blocking of synthesis of folic
acid. First SAs inhibit DHPS, which catalyzes the formation of dihydropteroic acid. Then TMP
inhibits DHFR, which catalyzes the formation of tetrahydrofolic acid from dihydrofolic acid.
In an acute mixture toxicity there were more SAs-binding-LUC and TMP-binding-LUC.
However, in chronic mixture toxicity, the concentration of SAs-binding-DHPS was less
compere to TMP-binding-DHFR. It can therefore be concluded that the dissimilarities in the
concentrations of individual chemical-binding receptor proteins also lead to the different joint
effect (SA with TMP) in acute and chronic mixture toxicity [61].
These examples highlight the fact that the simultaneous presence of several pharmaceuticals in
the environment may result in a higher level of toxicity towards non-target organisms than that
predicted for individual active substances. More ecotoxicological studies should therefore be
done to evaluate the impact of different mixtures of pharmaceuticals in non-target organisms.
5. Conclusions
The reason for concern regarding risks of mixtures is obvious. Man is always exposed to more
than one chemical at a time. This dictates the necessity of exposure assessment, hazard
identification, and risk assessment of chemical mixtures. However, for most chemical mixtures
data on exposure and toxicity are fragmentary, and roughly over 95% of the resources in
toxicology is still devoted to studies of single chemicals. Moreover, organisms are typically
exposed to mixtures of chemicals over long periods of time; thus, chronic mixture toxicity
analysis is the best way to perform risk assessment in regards to organisms.
However, testing of all kinds of (complex) mixtures of chemicals existing in the real world or of all
possible combinations of chemicals of a simple (defined) mixture at different dose levels is virtually
impossible. Moreover, even if toxicity data on individual compounds are available, we are still
facing the immense problem of extrapolation of findings obtained at relatively high exposure
concentration in laboratory animals to man being exposed to (much) lower concentrations.
As stated by several authors, it is essential to investigate if mixtures of pharmaceuticals interact,
leading to a larger effect in the environment than would be predicted when each compound
is considered individually. Mixtures with antibiotics in the environment may be very complex
(e.g. wastewater effluent) but they also may be simple. Although the latter may be more easily
studied experimentally, in both cases the identification and quantitative description of
synergism caused by specific substances is crucial.
Over past 10 years there has been increasing interest in the impacts of SAs and other veterinary
medicines in the environment and there is now a much better understanding about their environ‐
mental fate and their impacts on aquatic and terrestrial organisms. However, there are still a
number of uncertainties that require addressing before there can be a full understanding of the
environmental risks of these compounds. Areas requiring further research are presented below.
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• The assessment of the potential impacts of those SAs for which ecotoxicity data is lacking
but are seen to regularly occur in the environment.
• More information about the ecotoxicity of these compounds to soil organisms should be
provided. This regards to acute, chronic and single/mixture toxicity of most of the veterinary
pharmaceuticals.
• Information on the potential environmental effects of parent compounds (drugs) as well as
metabolites and transformation products. This includes the single and joint effects evalua‐
tion.
• Further research is required on the mixture toxicity of SAs in combination with other
medicines and non-medicinal substances.
• The possible indirect effects of SAs should be identified.
• Data from acute and chronic ecotoxicity tests on species belonging to different trophic levels
such as bacteria, algea, crustaceans and fish among others, is relevant to illustrate the several
adverse effects that environmental exposure to measured concentrations of these contami‐
nants can have. The principal toxicological endpoints/studies that are described are growth,
survival, reproduction and immobilization of species, comparatively to trangenerational
and population level studies that are still sparse. In the near future, the evaluation of chronic
toxicity effects should be set out as a priority for the scientific community since simultaneous
exposure to pharmaceuticals, metabolites and transformation products of several thera‐
peutic classes are unknown and whose probable effects on subsequent generations should
be assumed.
Abbreviations
Abbreviation Full name
CA Concentration Addition
DHFR Dihydrofolic Acid Reductase
DHPS Dihydropterinic Acid Synthetase
EPA Environmental Protection Agency
ERA Environmental Risk Assessment
IA Independent Action
LUC Lucyferase
MEC Measured Environmental Concentration
NOEC No Observable Effect Concentrations
PABA p-aminobenzoic acid
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Abbreviation Full name
PEC Predicted Environmental Concentration
PMT Pyrimethamine
PNEC Predicted Non-Effective Concentrations
RQ Risk Quotient
SAs Sulfonamides
SCP Sulfachloropyridazine
SDM Sulfadimethoxine
SDMD (SMZ) Sulfadimidine (Sulfamethazine)
SDZ Sulfadiazine
SGD Sulfaguanidine
SMP Sulfamethoxypyridazine
SMR Sulfamerazine
SMTZ Sulfamethiazole
SMX Sulfamethoxazole
SPY Sulfapyridine
SQO Sulfaquinoxaline
SSX Sulfisoxazole
STZ Sulfathiazole
TMP Trimethoprim
Table 5. List of abbreviations used in the text
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